Digital Biomarkers

Digital biomarkers are changing the face of clinical trials. By allowing for the collection of high-density data from wearables and apps, we can gain new, more powerful insights into the ability of novel therapeutics to modulate or modify disease. Biospective has performed multiple digital biomarker studies for its sponsors, and we have implemented processes for the acquisition, quality control, and analysis of this “Big Data”.

Validation of Novel Digital Health Technologies
Validation of Novel Digital Health Technologies


REB Submissions

 


Data and Project Management

 


Deployment of Digital Biomarkers in Multicenter Clinical Trials

 


Subject Recruitment
 


Statistical Analysis

 


Study Protocol Design

 


Functional Assessments

 


Final Report